Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Obama Touts Precision Medicine Initiative in State of the Union
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies President Barack Obama announced a new precision medicine initiative this week in his State of the Union Address. Also known as personalized medicine, expanding the government's focus on...
DNA-Based HPV Test OK For Primary Screening
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies DNA-based human papillomavirus tests can be used as a primary screening tool for cervical cancer in women 25 years of age and older, according to a controversial interim guidance published...
Cleveland HeartLab Acquires Proprietary Cardiac Risk Algorithm Technology
By Ron Shinkman, Editor, Laboratory Industry Report The Ohio-based Cleveland HeartLab (CHL) has acquired technology developed by Stanford University that can more accurately predict the likelihood of heart attacks. Known as MIRISK, its nucleus is an algorithm that...
Roche to Take Majority Stake in Foundation Medicine
By Stephanie Murg, Managing Director, G2 Intelligence Roche is betting big on cancer genomics. The Swiss pharmaceutical giant has agreed to acquire a majority stake in Foundation Medicine (Cambridge, Mass.), which uses genetic sequencing to optimize treatment...
Pharmaceutical Company Uses Speaker Fees To Provide Kickbacks
By Christopher P. Young, Editor, G2 Compliance Advisor Pharmaceutical company Daiichi Sankyo Inc. paid $39 million and agreed to enter into a five-year Corporate Integrity Agreement to settle government allegations of using speaker fees and lavish dinners as a...
FDA Workshop Continues the Debate About LDT Regulation
By Kelly A. Briganti, JD, Editorial Director, G2 Intelligence The debate regarding FDA regulation of laboratory developed tests (LDTs) continues to swirl as the FDA held a two-day workshop providing a forum for public comment from more than 80 presenters. The...
CDC Seeks Collaborator in Achieving Earlier HIV Detection
By Kelly A. Briganti, JD, Editorial Director, G2 Intelligence In keeping with Medicare's expanded coverage of HIV screenings aimed at achieving earlier detection of the virus (see National Intelligence Report, Feb. 12, 2015), the CDC is also focusing on earlier and...